Tjitske De Boer-Duiveman

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity.

Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity.

Journal: Oncoimmunology
Published: July 01, 2026

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands.

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands.

Journal: BMJ open
Published: November 10, 2025

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis.

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis.

Journal: BMJ open
Published: September 12, 2024

Distinct roles of PGE2 signaling via EP2 and EP4 in circulating pDCs: Implications for immune modulation in the tumor microenvironment.

Distinct roles of PGE2 signaling via EP2 and EP4 in circulating pDCs: Implications for immune modulation in the tumor microenvironment.

Journal: Journal of leukocyte biology
Published: August 06, 2024

Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.

Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.

Journal: Methods in cell biology
Published: March 28, 2024

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Journal: Nature communications
Published: May 09, 2023

Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer.

Whole Blood Transcriptome Profiling Identifies DNA Replication and Cell Cycle Regulation as Early Marker of Response to Anti-PD-1 in Patients with Urothelial Cancer.

Journal: Cancers
Published: July 27, 2021

Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Journal: Frontiers in oncology
Published: February 26, 2021

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.

Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.

Journal: Frontiers in immunology
Published: October 22, 2018

Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.

Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.

Journal: International journal of molecular sciences
Published: December 22, 2017

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Journal: Oncoimmunology
Published: April 11, 2016

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.

Journal: Oncoimmunology
Published: January 13, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026